Gerresheimer Stock - Long-term strategy and specialty pharma packaging focus
20.06.2026 - 13:05:30 | ad-hoc-news.de
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 11:04 UTC. Details in the imprint.
Gerresheimer (DE000A0LD6E6) is a specialist supplier of primary packaging and drug delivery systems for the pharmaceutical and biotech industry. With no new ad-hoc announcements or analyst rating changes today, the focus shifts to its long-term strategy and structural growth profile.
All news and data on Gerresheimer stock
Key figures, ad-hoc releases and further price data on Gerresheimer stock can be found in the dedicated topic section and on the company’s investor relations pages.
How Gerresheimer positions itself
Gerresheimer AG describes itself as a global partner for primary packaging and drug delivery systems, serving pharma, biotech and healthcare customers in more than 40 locations worldwide according to its latest company profile. Company profile on Gerresheimer
The group focuses on three broad areas: glass packaging such as vials and cartridges, plastic containers and closures, and complex devices including prefillable syringes, inhalers and insulin pens for injectable therapies.
Long-term strategy and growth drivers
Strategically, management emphasizes becoming an integrated systems and solutions provider, moving beyond standard containers to higher-margin, customized drug delivery and containment solutions for injectable and biotech medicines. Gerresheimer annual report overview
Structural drivers include aging populations, rising chronic disease burdens and steady growth in biologics, all of which require sophisticated, high-quality primary packaging and device solutions to ensure drug stability and patient safety.
What the company sells
Gerresheimer’s portfolio spans borosilicate glass vials and cartridges, prefillable glass and plastic syringes, specialty plastic containers for solid and liquid drugs, and complex drug delivery devices such as inhalers, autoinjectors and insulin pens for leading pharmaceutical customers.
Where the stock trades today
Gerresheimer shares (DE000A0LD6E6) trade on Xetra in euros; the latest price, market capitalization and intraday data are available on Deutsche Börse and common financial data platforms.
Key facts on Gerresheimer stock
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Venue: Xetra
- Price (as of latest available Xetra close): data available via Deutsche Börse and major financial portals in EUR
- Market cap: market capitalization data available on the same sources based on the current share price
- Sector / Industry: Health Care - Pharmaceuticals packaging and medical supplies
- Index membership: MDAX
- Next earnings date: next reporting date as stated in the company’s financial calendar
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
